Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in 
amnestic mild cognitive impairment and are unrelated to amyloid deposition and 
apolipoprotein E genotype

Riese, R; Gietl, A; Zölch, N; Henning, A; O’Gorman, R; Kälin, AM; Leh, SE; Buck, A; Warnock, G; Edden, RAE; Luechinger, R; Hock, C; Kollias, S; Michels, L

doi:10.1016/j.neurobiolaging.2014.07.030

Local TagsRelease HistoryDetailsSummary

Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype

Riese, R., Gietl, A., Zölch, N., Henning, A., O’Gorman, R., Kälin, A., et al. (2015). Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype. Neurobiology of Aging, 36(1), 53-59. doi:10.1016/j.neurobiolaging.2014.07.030.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-002A-479B-7 Version Permalink: https://hdl.handle.net/21.11116/0000-0001-1F12-9

Genre: Journal Article

Files

show Files

Locators

show

hide

Locator:
http://www.sciencedirect.com/science/article/pii/S0197458014004990 (Publisher version) Open Access status unknown

Description:
-

OA-Status:

Creators

show

hide

Creators:
Riese, R, Author
Gietl, A, Author
Zölch, N, Author
Henning, A^{1, 2}, Author
O’Gorman, R, Author
Kälin, AM, Author
Leh, SE, Author
Buck, A, Author
Warnock, G, Author
Edden, RAE, Author
Luechinger, R, Author
Hock, C, Author
Kollias, S, Author
Michels, L, Author

Affiliations:
1Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society, Spemannstrasse 38, 72076 Tübingen, DE, ou_2528692
2Max Planck Institute for Biological Cybernetics, Max Planck Society, Spemannstrasse 38, 72076 Tübingen, DE, ou_1497794

Content

show

hide

Free keywords: -

Abstract: The biomarker potential of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) for the in vivo characterization of preclinical stages in Alzheimer’s disease (AD) has not yet been explored. We measured GABA, glutamate+glutamine (Glx) and N-acetyl-aspartate (NAA) levels by single-voxel MEGA-PRESS magnetic resonance spectroscopy in the posterior cingulate cortex (PCC) of 21 elderly subjects and 15 patients with amnestic mild cognitive impairment. Participants underwent Pittsburgh Compound B (PiB) positron emission tomography, apolipoprotein E (APOE) genotyping, and neuropsychological examination. GABA, Glx, and NAA levels were significantly lower in patients. NAA was lower in PiB-positive subjects and APOE ε4 allele carriers. GABA, Glx, and NAA levels were positively correlated to CERAD word learning scores. Reductions in GABA, Glx and NAA levels may serve as metabolic biomarkers for cognitive impairment in aMCI. Since GABA and Glx do not seem to reflect amyloid β deposition or APOE genotype, they are less likely biomarker candidates for preclinical AD.

Details

show

hide

Language(s):

Dates: Date issued: 2015-01

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: DOI: 10.1016/j.neurobiolaging.2014.07.030
BibTex Citekey: RieseGZHOKLBWELHKM2014

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Neurobiology of Aging

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 36 (1) Sequence Number: - Start / End Page: 53 - 59 Identifier: -